Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Chevret

Showing results (181-190 of 226) with videos related to

Pageof 23
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 19, 2015
Rituximab and risk of second primary malignancies in patients with non-Hodgkin lymphoma: a systematic review and meta-analysisI Fleury, S Chevret, M Pfreundschuh, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|February 15, 2002
Induction of labour with a viable infant: a randomised clinical trial comparing intravaginal misoprostol and intravaginal dinoprostoneP Rozenberg, S Chevret, F Goffinet, et al.
Blood|October 27, 1998
High-dose therapy and autologous peripheral blood stem cell transplantation in multiple myeloma: up-front or rescue treatment? Results of a multicenter sequential randomized clinical trialJ P Fermand, P Ravaud, S Chevret, et al.
Intensive Care Medicine|August 18, 2011
Time course of organ failure in patients with septic shock treated with hydrocortisone: results of the Corticus studyR Moreno, C L Sprung, D Annane, et al.
Blood|July 18, 2001
Relationship between HLA alleles and cytomegalovirus infection after allogenic hematopoietic stem cell transplantY Chen, V Rocha, H Bittencourt, et al.
British Journal of Cancer|July 19, 2006
A phase I dose-finding and pharmacokinetic study of subcutaneous semisynthetic homoharringtonine (ssHHT) in patients with advanced acute myeloid leukaemiaV Lévy, S Zohar, C Bardin, et al.
Leukemia|July 30, 2003
Myelodysplastic syndrome after acute promyelocytic leukemia: the European APL group experienceI Lobe, F Rigal-Huguet, A Vekhoff, et al.
Bone Marrow Transplantation|April 20, 2010
Tandem autologous non-myeloablative allogeneic transplantation in patients with multiple myeloma relapsing after a first high dose therapyL Karlin, B Arnulf, S Chevret, et al.
HIV Medicine|April 6, 2005
Factors associated with virological response in HIV-infected patients failing antiretroviral therapy: a prospective cohort studyS Fournier, C Chaffaut, A Maillard, et al.
Leukemia|June 25, 1998
RAS, FMS and p53 mutations and poor clinical outcome in myelodysplasias: a 10-year follow-upR A Padua, B A Guinn, A I Al-Sabah, et al.
Pageof 23

Showing results (181-190 of 226) with videos related to

Sort By:
Pageof 23
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 19, 2015
Rituximab and risk of second primary malignancies in patients with non-Hodgkin lymphoma: a systematic review and meta-analysisI Fleury, S Chevret, M Pfreundschuh, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|February 15, 2002
Induction of labour with a viable infant: a randomised clinical trial comparing intravaginal misoprostol and intravaginal dinoprostoneP Rozenberg, S Chevret, F Goffinet, et al.
Blood|October 27, 1998
High-dose therapy and autologous peripheral blood stem cell transplantation in multiple myeloma: up-front or rescue treatment? Results of a multicenter sequential randomized clinical trialJ P Fermand, P Ravaud, S Chevret, et al.
Intensive Care Medicine|August 18, 2011
Time course of organ failure in patients with septic shock treated with hydrocortisone: results of the Corticus studyR Moreno, C L Sprung, D Annane, et al.
Blood|July 18, 2001
Relationship between HLA alleles and cytomegalovirus infection after allogenic hematopoietic stem cell transplantY Chen, V Rocha, H Bittencourt, et al.
British Journal of Cancer|July 19, 2006
A phase I dose-finding and pharmacokinetic study of subcutaneous semisynthetic homoharringtonine (ssHHT) in patients with advanced acute myeloid leukaemiaV Lévy, S Zohar, C Bardin, et al.
Leukemia|July 30, 2003
Myelodysplastic syndrome after acute promyelocytic leukemia: the European APL group experienceI Lobe, F Rigal-Huguet, A Vekhoff, et al.
Bone Marrow Transplantation|April 20, 2010
Tandem autologous non-myeloablative allogeneic transplantation in patients with multiple myeloma relapsing after a first high dose therapyL Karlin, B Arnulf, S Chevret, et al.
HIV Medicine|April 6, 2005
Factors associated with virological response in HIV-infected patients failing antiretroviral therapy: a prospective cohort studyS Fournier, C Chaffaut, A Maillard, et al.
Leukemia|June 25, 1998
RAS, FMS and p53 mutations and poor clinical outcome in myelodysplasias: a 10-year follow-upR A Padua, B A Guinn, A I Al-Sabah, et al.
Pageof 23